Crossmark

Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device

Crossref DOI link: https://doi.org/10.1007/s00345-019-02698-7

Published Online: 2019-02-26

Published Print: 2019-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yaoguang

Zhang, Peng

Tian, Xiaojun

Chen, Guoqing

Li, Yan

Zhang, Yong

Xu, Zhihui

Wei, Zhongqing

Zhang, Wei

Ma, Lulin

Shi, Benkang

Liao, Limin

Wang, Jianye
Funding

Funding for this research was provided by:

National Key R&D Program of China (2016YFC0105500)

the National Key R&D Program of China (2018YFC2002200)
License Information

Text and Data Mining valid from 2019-02-26
More Information

Article History

Received: 5 December 2018

Accepted: 19 February 2019

First Online: 26 February 2019

Compliance with ethical standards

:

: The authors declare that they have no competing interests.

: All the procedures performed involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below